311 related articles for article (PubMed ID: 15498502)
21. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
22. Pantoprazole lacks induction of CYP1A2 activity in man.
Hartmann M; Zech K; Bliesath H; Steinijans VW; Koch H; Wurst W; Mascher H
Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
[TBL] [Abstract][Full Text] [Related]
23. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1992 Aug; 218(2-3):265-71. PubMed ID: 1330598
[TBL] [Abstract][Full Text] [Related]
24. Lack of pantoprazole drug interactions in man: an updated review.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
[TBL] [Abstract][Full Text] [Related]
25. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
26. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
27. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole.
Huber R; Kohl B; Sachs G; Senn-Bilfinger J; Simon WA; Sturm E
Aliment Pharmacol Ther; 1995 Aug; 9(4):363-78. PubMed ID: 8527612
[TBL] [Abstract][Full Text] [Related]
28. Synthesis or rupture: duration of acid inhibition by proton pump inhibitors.
Sachs G; Shin JM; Pratha V; Hogan D
Drugs Today (Barc); 2003 Mar; 39 Suppl A():11-4. PubMed ID: 12712216
[TBL] [Abstract][Full Text] [Related]
29. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
[TBL] [Abstract][Full Text] [Related]
30. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
[TBL] [Abstract][Full Text] [Related]
31. BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.
Kromer W; Postius S; Riedel R; Simon WA; Hanauer G; Brand U; Gönne S; Parsons ME
J Pharmacol Exp Ther; 1990 Jul; 254(1):129-35. PubMed ID: 2164086
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
Andersson T; Holmberg J; Röhss K; Walan A
Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
[TBL] [Abstract][Full Text] [Related]
33. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
34. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
[TBL] [Abstract][Full Text] [Related]
35. The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
Shin JM; Besancon M; Simon A; Sachs G
Biochim Biophys Acta; 1993 Jun; 1148(2):223-33. PubMed ID: 8389196
[TBL] [Abstract][Full Text] [Related]
36. Pantoprazole (Protonix).
Med Lett Drugs Ther; 2000 Jul; 42(1083):65-6. PubMed ID: 10908422
[No Abstract] [Full Text] [Related]
37. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
[TBL] [Abstract][Full Text] [Related]
38. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
Sharara AI
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
[TBL] [Abstract][Full Text] [Related]
39. Continuing development of acid pump inhibitors: site of action of pantoprazole.
Shin JM; Besancon M; Prinz C; Simon A; Sachs G
Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
[TBL] [Abstract][Full Text] [Related]
40. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
